Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber, will highlight its portfolio of thermoplastic elastomers (TPEs) at the Healthcare Elastomer Conference from May 21-22 in Schaumburg, Illinois. The conference is sponsored by Rubber & Plastics News, broadly focusing on TPEs and the best ways to incorporate them into application designs.
In the medical devices market, soft-touch materials and overlays are often needed along with hard plastics. Recent trends in the industry, such as home healthcare, self-administered care, and an aging population, require medical devices and equipment that are patient and service provider friendly.
Trinseo offers two styrenic block copolymers (TPSs) to meet this marketplace need under the brands MEGOL™ TPS-SEBS Compounds and RAPLAN™ TPS-SBC Compounds. Materials range from highly elastomeric and opaque to semi-rigid and transparent and can be used for injection molding, extrusion, or soft-touch overlays. MEGOL™ and RAPLAN™ materials are available with a full battery of ISO 10993 biocompatibility tests (MED). MEGOL™ materials are also available with limited biocompatibility testing for skin contact (SK) applications.
Trinseo added TPEs to complement its portfolio of rigid plastics in 2017 when it acquired API, a manufacturer of thermoplastic elastomeric compounds and bioplastics. As a result, Trinseo is able to offer customers the convenience of obtaining both their rigid and soft-touch plastics from one source and the advantage of a single point of contact for overmolding solutions.
Trinseo supports medical device customers with material solutions for Single and Multiple Use Devices, Equipment Housings, Drug Delivery Systems, and Medical Wearables. In addition to TPEs, Trinseo is known globally for its rigid plastics brands including CALIBRE™ and CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advance Resins, and MAGNUM™ ABS Resins. Trinseo adheres to current Good Manufacturing Practices (cGMP) and holds an ISO 13485 certification.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.